Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy

被引:18
|
作者
Vijande, Javier [1 ,2 ]
Ballester, Facundo [1 ]
Ouhib, Zoubir [3 ]
Granero, Domingo [4 ]
Carmen Pujades-Claumarchirant, M. [5 ]
Perez-Calatayud, Jose [5 ]
机构
[1] Univ Valencia, Dept Atom Mol & Nucl Phys, E-46100 Burjassot, Spain
[2] Univ Valencia, CSIC, IFIC, Paterna, Valencia, Spain
[3] Boca Raton Reg Hosp, Lynn Canc Inst, Boca Raton, FL USA
[4] Hosp Gen Univ, ERESA, Dept Radiat Phys, Valencia, Spain
[5] La Fe Univ Hosp, Dept Radiat Oncol, Valencia, Spain
关键词
Ir-192; Brachytherapy; Dosimetry; Penelope2008; Freiburg flap; PARAMETERS; IR-192; APPLICATORS;
D O I
10.1016/j.brachy.2011.11.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: The purpose of this work was to evaluate whether the delivered dose to the skin surface and at the prescription depth when using a Freiburg flap applicator is in agreement with the one predicted by the treatment planning system (TPS) using the TG-43 dose-calculation formalism. METHODS AND MATERIALS: Monte Carlo (MC) simulations and radiochromic film measurements have been performed to obtain dose distributions with the source located at the center of one of the spheres and between two spheres. Primary and scatter dose contributions were evaluated to understand the role played by the scatter component. A standard treatment plan was generated using MC- and TG-43-based TPS applying the superposition principle. RESULTS: The MC model has been validated by performing additional simulations in the same conditions but transforming air and Freiburg flap materials into water to match TG-43 parameters. Both dose distributions differ less than 1%. Scatter defect compared with TG-43 data is up to 15% when the source is located at the center of the sphere and up to 25% when the source is between two spheres. Maximum deviations between TPS- and MC-based distributions are of 5%. CONCLUSIONS: The deviations in the TG-43-based dose distributions for a standard treatment plan with respect to the MC dose distribution calculated taking into account the composition and shape of the applicator and the surrounding air are lower than 5%. Therefore, this study supports the validity of the TPS used in clinical practice. (C) 2012 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:528 / 535
页数:8
相关论文
共 50 条
  • [41] End-to-end test and MOSFET in vivo skin dosimetry for 192Ir high-dose-rate brachytherapy of chronic psoriasis
    Tuntipumiamorn, Lalida
    Nakkrasae, Pitchayut
    Kongkum, Sansanee
    Dankulchai, Pittaya
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2019, 11 (04) : 384 - 391
  • [42] On the use of the absorbed depth-dose measurements in the beam calibration of a surface electronic high-dose-rate brachytherapy unit, a Monte Carlo-based study
    Valdes-Cortez, Christian
    Niatsetski, Yury
    Ballester, Facundo
    Vijande, Javier
    Candela-Juan, Cristian
    Perez-Calatayud, Jose
    MEDICAL PHYSICS, 2020, 47 (02) : 693 - 702
  • [43] High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds - a single-centre experience
    Laliscia, Concetta
    Fuentes, Taiusha
    Coccia, Natalina
    Mattioni, Roberto
    Perrone, Franco
    Paiar, Fabiola
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2021, 25 (01): : 12 - 16
  • [44] 32P Brachytherapy Conformal Source Model RIC-100 for High-Dose-Rate Treatment of Superficial Disease: Monte Carlo Calculations, Diode Measurements, and Clinical Implementation
    Cohen, Gil'ad N.
    Munro, John J., III
    Kirov, Assen
    Losasso, Thomas
    Yamada, Yoshiya
    Williamson, Matthew
    Dauer, Lawrence T.
    Zaider, Marco
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (03): : 746 - 752
  • [45] The effect of rib and lung heterogeneities on the computed dose to lung in Ir-192 High-Dose-Rate breast brachytherapy: Monte Carlo versus a treatment planning system
    Yazdi, Hossein Salehi
    Shamsaei, Mojtaba
    Jaberi, Ramin
    Shabani, Hamid Reza
    Allahverdi, Mahmoud
    Vaezzadeh, Seyed Ali
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (03) : 394 - 398
  • [46] Monte Carlo dose calculations of beta-emitting sources for intravascular brachytherapy: A comparison between EGS4, EGSnrc, and MCNP
    Wang, RQ
    Li, XA
    MEDICAL PHYSICS, 2001, 28 (02) : 134 - 141
  • [47] In vivo dosimetry of high-dose-rate brachytherapy:: Study on 61 head-and-neck cancer patients using radiophotoluminescence glass dosimeter
    Nose, T
    Koizumi, M
    Yoshida, K
    Nishiyama, K
    Sasaki, J
    Ohnishi, T
    Peiffert, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (03): : 945 - 953
  • [48] Freiburg flap used as vaginal applicator with/without free-hand interstitial needles in three-dimensional high-dose-rate brachytherapy for vaginal stump recurrence of cervical cancer
    He, Mingyuan
    Zhao, Hongfu
    Zhang, Yuqing
    Zhang, Ning
    Zhao, Zhipeng
    Cheng, Guanghui
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2024, 16 (05) : 344 - 351
  • [49] In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer
    Anagnostopoulos, G
    Baltas, D
    Geretschlaeger, A
    Martin, T
    Papagiannis, P
    Tselis, N
    Zamboglou, N
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (04): : 1183 - 1191
  • [50] Evaluation of bone dose arising from skin cancer brachytherapy: A comparison between 192Ir and 60Co sources through Monte Carlo simulations
    Sheikholeslami, Sahar
    Khodaverdian, Shaghayegh
    Hashemzaei, Fatemeh
    Ghobadi, Parvin
    Ghorbani, Mahdi
    Farhood, Bagher
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2021, 205